(Q54618926)
Statements
Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib. (English)
William Pao
1 reference
Yelena Y Janjigian
Christopher G Azzoli
Lee M Krug
Leanne K Pereira
Naiyer A Rizvi
M Catherine Pietanza
Michelle S Ginsberg
Vincent A Miller
Gregory J Riely
19 January 2011
17
8
2521-2527